Particularly, PAI-1 level is significantly elevated in plasma from patients with cirrhosis and hepatocellular carcinoma following HCV infection compared to that of uninfected healthy donors [10,35]. This evidence concerns the gene SERPINE1 and hepatocellular carcinoma.